Abbott Receives the US FDA’s Clearance for Alinity H-Series Hematology System

Share this

Abbott Receives the US FDA’s Clearance for Alinity H-Series Hematology System


  • The US FDA has cleared the advanced Alinity h-series hematology system enabling laboratories to run complete blood counts (CBCs) as part of Abbott’s Alinity family of diagnostic products. The system will seamlessly integrate into existing Alinity lab systems across the country
  • The system incl. the Alinity HQ automated hematology analyzer and the Alinity HS integrated slide maker and stainer. The Alinity HQ uses Abbott's Multi-Angle Polarized Scatter Separation (MAPSS) technology which utilizes light scattering to distinguish cellular features and better identify various blood cells     
  • The Alinity family now includes the Alinity CI for clinical chemistry and immunoassays, the Alinity M for molecular testing, the Alinity S for transfusion, and the point-of-care i-STAT Alinity

Ref: PR Newswire | Image: Abbott

Related News:- Abbott’s AVEIR Dual Chamber Leadless Pacemaker System Receives the US FDA’s Approval for Abnormal or Slow Heart Rhythms

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com 

Click here to­ read the full press release 

Senior Editor

Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions